Publication Name	World Journal of Gastroenterology
Manuscript ID	96129
Country	China

Received	2024-04-27 16:53
Peer-Review Started	2024-04-27 16:53
To Make the First Decision
Return for Revision	2024-05-15 20:51
Revised	2024-05-27 10:48
Second Decision	2024-06-13 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-13 03:07
Articles in Press	2024-06-13 03:07
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-06-20 05:51
Publish the Manuscript Online	2024-06-25 10:41

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Gastric microbiota transplantation as a potential treatment for immune checkpoint inhibitor-associated gastritis
Manuscript Source	Invited Manuscript
All Author List	Bo-Tong Ma, Li-Xuan Sang and Bing Chang
ORCID	Author(s) ORCID Number Bo-Tong Ma http://orcid.org/0009-0009-7180-2602 Li-Xuan Sang http://orcid.org/0000-0002-4562-0022 Bing Chang http://orcid.org/0000-0003-1965-5827
Funding Agency and Grant Number
Corresponding Author	Bing Chang, MD, PhD, Chief Physician, Professor, Department of Gastroenterology, The First Affiliated Hospital of China Medical University, No. 155, Nanjing North Street, Shenyang 110001, Liaoning Province, China. cb000216@163.com
Key Words	Immune checkpoint inhibitor; Immune-related adverse events; Gastritis; Gastric microbiota transplantation; Probiotics
Core Tip	The gastric microbiota is often related to the occurrence and development of many gastric diseases. Faecal microbiota transplantation has been used for treating immune checkpoint inhibitor (ICI)-associated colitis. Therefore, gastric microbiota transplantation is a promising treatment for ICI-associated gastritis.
Publish Date	2024-06-25 10:41
Citation	<p>Ma BT, Sang LX, Chang B. Gastric microbiota transplantation as a potential treatment for immune checkpoint inhibitor-associated gastritis. <i>World J Gastroenterol</i> 2024; 30(24): 3123-3125</p>
URL	https://www.wjgnet.com/1007-9327/full/v30/i24/3123.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i24.3123

Full Article (PDF)	WJG-30-3123-with-cover.pdf
Manuscript File	96129_Auto_Edited-YJP.docx
Answering Reviewers	96129-answering-reviewers.pdf
Audio Core Tip	96129-audio.mp3
Conflict-of-Interest Disclosure Form	96129-conflict-of-interest-statement.pdf
Copyright License Agreement	96129-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	96129-non-native-speakers.pdf
Peer-review Report	96129-peer-reviews.pdf
Scientific Misconduct Check	96129-scientific-misconduct-check.png
Scientific Editor Work List	96129-scientific-editor-work-list.pdf
CrossCheck Report	96129-crosscheck-report.pdf